BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12893196)

  • 1. Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary.
    Mori Y; Nishii H; Takabe K; Shinozaki H; Matsumoto N; Suzuki K; Tanabe H; Watanabe A; Ochiai K; Tanaka T
    Gynecol Oncol; 2003 Aug; 90(2):338-41. PubMed ID: 12893196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
    Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary.
    Kikkawa F; Nawa A; Tamakoshi K; Ishikawa H; Kuzuya K; Suganuma N; Hattori S; Furui K; Kawai M; Arii Y
    Cancer; 1998 Jun; 82(11):2249-55. PubMed ID: 9610706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of frozen sections and serum markers in invasive squamous cell carcinoma arising from ovarian mature cystic teratoma: two case reports.
    Tazo Y; Yoshimura Y; Shoda T; Kyushima N; Okada T; Yamazaki H
    J Med Case Rep; 2016 Jan; 10():20. PubMed ID: 26801904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can malignant transformation in mature cystic teratoma be preoperatively predicted?
    Futagami M; Yokoyama Y; Mizukami H; Shigeto T; Mizunuma H
    Eur J Gynaecol Oncol; 2012; 33(6):662-5. PubMed ID: 23327068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative diagnosis of malignant transformation in mature cystic teratoma of the ovary.
    Yamanaka Y; Tateiwa Y; Miyamoto H; Umemoto Y; Takeuchi Y; Katayama K; Hashimoto K
    Eur J Gynaecol Oncol; 2005; 26(4):391-2. PubMed ID: 16122185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant mature ovarian cystic teratoma including more than 300 teeth.
    Devoize L; Collangettes D; Le Bouëdec G; Mishellany F; Orliaguet T; Dallel R; Baudet-Pommel M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):e76-9. PubMed ID: 18280952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.
    Nanki Y; Chiyoda T; Kataoka F; Nomura H; Nakadaira N; Iwasa N; Hashimoto S; Arima H; Susumu N; Aoki D
    J Obstet Gynaecol Res; 2017 Apr; 43(4):744-748. PubMed ID: 28370831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study.
    Chiang AJ; Chen MY; Weng CS; Lin H; Lu CH; Wang PH; Huang YF; Chiang YC; Yu MH; Chang CL
    J Gynecol Oncol; 2017 Sep; 28(5):e69. PubMed ID: 28657230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of 44 cases with malignant transformation of ovarian mature cystic teratoma].
    An JS; Wu LY; Li XG; Zhang R; Song Y; Ma SK; Liu LY; Hong WJ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):123-8. PubMed ID: 23544494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
    Kataoka T; Watanabe Y; Hoshiai H
    J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transvaginal color Doppler ultrasonic characterization of benign and malignant ovarian cystic teratomas and comparison with serum squamous cell carcinoma antigen.
    Emoto M; Obama H; Horiuchi S; Miyakawa T; Kawarabayashi T
    Cancer; 2000 May; 88(10):2298-304. PubMed ID: 10820352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Frequency of Malignant Transformation of Ovarian Mature Teratoma into Squamous Cell Carcinoma in Young Patients in Northeast Brazil.
    Araujo IB; Pinheiro MV; Zanvettor PH; Studart EJ; Filho DF; Coupland SE
    Int J Gynecol Pathol; 2016 Mar; 35(2):176-84. PubMed ID: 26367783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant transformation arising from mature ovarian cystic teratoma: A case series.
    Qin L; Zhao T; Liu X; Wang H; Gu X; Chen D; Wang Z; He D
    Medicine (Baltimore); 2021 Apr; 100(13):e24726. PubMed ID: 33787574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of squamous cell carcinoma antigen in squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M; Kobayashi H; Sekiguchi I; Konnai K; Terao T; Sato I
    Oncology; 1995; 52(4):287-90. PubMed ID: 7777241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and molecular studies on malignant transformation in mature cystic teratoma of the ovary.
    Yoshioka T; Tanaka T
    J Obstet Gynaecol Res; 1998 Apr; 24(2):83-90. PubMed ID: 9631595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
    Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
    Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma arising from respiratory ciliated epithelium in mature ovarian cystic teratoma.
    Sumi T; Ishiko O; Maeda K; Haba T; Wakasa K; Ogita S
    Arch Gynecol Obstet; 2002 Dec; 267(2):107-9. PubMed ID: 12439559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative clinical characteristics for differentiating malignant transformation from torsion of mature cystic teratoma.
    Chen H; Wang F; Hu X; Dai X; Wang Y
    J Obstet Gynaecol; 2023 Dec; 43(1):2151357. PubMed ID: 36519361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma in mature cystic teratoma of the ovary induced by human papillomavirus 16 infection: A case report and literature review.
    Shi Z; Yang L; Bian C
    Medicine (Baltimore); 2022 Sep; 101(38):e30667. PubMed ID: 36197169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.